首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >In vitro antimicrobial activity of cefoperazone cefotaxime moxalactam (LY127935) azlocillin mezlocillin and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae including beta-lactamase-producing strains.
【2h】

In vitro antimicrobial activity of cefoperazone cefotaxime moxalactam (LY127935) azlocillin mezlocillin and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae including beta-lactamase-producing strains.

机译:头孢哌酮头孢噻肟莫拉西坦(LY127935)azlocillinmezlocillin和其他β-内酰胺抗生素对淋病奈瑟氏球菌和流感嗜血杆菌的体外抗菌活性包括产生β-内酰胺酶的菌株。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Minimum inhibitory concentrations and agar disk diffusion tests were determined on clinical isolates of beta-lactamase-positive and beta-lactamase-negative Neisseria gonorrhoeae and Haemophilus influenzae with the newer beta-lactam antibiotics, cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and piperacillin, and with seven older beta-lactam antibiotics. All the drugs were active against beta-lactamase-negative strains of N. gonorrhoeae and H. influenzae. The drug most active against beta-lactamase-positive N. gonorrhoeae was cefotaxime, followed closely by cefoperazone, moxalactam, piperacillin, and mezlocillin. The drugs most active against beta-lactamase-positive strains of H. influenzae were cefotaxime, moxalactam, cefoperazone, and cefamandole.
机译:确定了β-内酰胺酶阳性和β-内酰胺酶阴性的淋病奈瑟氏球菌和流感嗜血杆菌的临床分离物的最低抑菌浓度和琼脂圆盘扩散试验,以及新型的β-内酰胺类抗生素,头孢哌酮,头孢噻肟,莫拉西坦(LY127935),阿洛西林,美洛西林,哌拉西林和7种较旧的β-内酰胺类抗生素。所有药物均对淋病奈瑟氏球菌和流感嗜血杆菌的β-内酰胺酶阴性菌株具有活性。对β-内酰胺酶阳性淋病奈瑟氏球菌最有效的药物是头孢噻肟,其次是头孢哌酮,莫拉西坦,哌拉西林和美洛西林。对流感嗜血杆菌的β-内酰胺酶阳性菌株最有效的药物是头孢噻肟,莫拉西坦,头孢哌酮和头孢曼多。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号